Home

NATCO Pharma Limited

NATCOPHARM.NSNSEHealthcare
₹909.00Today0.16% · -₹1.50
Day rangeTrading above day high
₹0.00₹0.00
Open
₹0.00
Prev close
₹910.50
AskWarren SignalsUpdated 22:31 IST
Momentum Bearish(-0.16% today)Volume 28% Above Avg52W Position Mid-range
Volume
4.1L
28% above avg
Avg vol (20D)
3.2L
20-day baseline
Mkt cap
₹16,245.27Cr
Small Cap
P/E TTM
11.5×

Trade NATCO Pharma Limited with Artha

Sign in to place orders, set alerts, and sync your watchlist.

Sign in to trade

NATCO Pharma Limited, a pharmaceutical company, engages in the research and development, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally. The company offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, and ovary; and APIs in various categories, such as oncology, central nervous system, pain management, and cardiovascular care. It also provides orthopedic products comprising bisphosphonates, which are oral and injectable drugs; and gastroenterology products consisting of novel drugs for chronic hepatitis-B and hepatitis-C, as well as contract manufacturing services. In addition, the company offers neurology, cardiology and diabetology products for the treatment of hypertension, stable angina, and CHF. Further, the company provides agro chemicals and biological pest management solutions for management of insects, diseases, and weeds across a range of crops. NATCO Pharma Limited was incorporated in 1981 and is headquartered in Hyderabad, India.

Classification

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Stock ExchangeNSE

Identifiers

Ticker SymbolNATCOPHARM.NS

Company Info

HeadquartersNot available
Employees0
Save watchlists across devicesSet price alerts that buzz your phoneConnect Zerodha for one-tap trades
Create free account

We use analytics cookies to understand how you use Artha and improve your experience. No data is sold to third parties.

NATCO Pharma Limited (NATCOPHARM) Stock Price & Analysis | Artha